Although South Africa's wider food industry is comfortably Africa's most advanced, the market remains some way behind most developed states when it comes to organics. Food production is a major manufacturing sector, accounting for about 15% of overall domestic production. The sector is highly competitive, with more than 1,800 food production companies. However, 10 large players dominate the industry, accounting for 68% of total turnover.

Oil wealth has facilitated development of sophisticated healthcare system. The largest medical device market in the Middle East and Africa region. Market size reduced and market forecast revised upwards in December 2017. Reliant on imports, primarily from the US and Western Europe. Other medical devices and consumables have large market shares. improving regulations, which are approaching standards seen in developed states. Limited direct presence of multinational companies.

Saudi Arabia's construction industry remains largely dominated by domestic firms, many of which have close ties to the government and are often first in line for major public contracts. Foreign firms are gradually gaining market shares, with South Korean and US firms targeting industrial projects while several major European firms are involved in transport and energy projects. The broad range of projects in the pipeline does mean opportunities are present for domestic and international firms, although the latter will be presented with challenges in the form of a restrictive operating environment.

Largest medical device market in the Central & Eastern Europe (CEE) region. Per capita spending is low for the CEE region.Market will record moderate growth in US dollar terms. Other medical devices and diagnostic imaging have the largest market shares. The government has increased the number of medical devices subject to import restrictions, which could negatively impact the sales of foreign manufacturers. Import shares may fall by 2020, in accordance with the Ministry of Industry and Trade's import substitution plan, which aims to reduce the import shares of 111 groups of medical devices. The greatest opportunities exist around the major cities of Moscow and St Petersburg, where most companies are based and per capita incomes are well above the national average.

Romania is one of the largest pharmaceutical markets in the Central and Eastern European region. However, its low per capita medicine expenditure reflects its relative lack of development compared to its more prominent Central European peers such as Poland, Czech Republic and Hungary. As such, growth opportunities are significant.

Eighth largest Central & Eastern European (CEE) market. Per capita spending is below the CEE average. The market will grow by a high US dollar CAGR. • Other medical devices and diagnostic imaging have the largest market shares. There is little local production, so much of the market is largely reliant on imports. The health sector is historically underdeveloped, poorly funded and poorly managed. Growing private healthcare sector. Continued World Bank support should maintain progress in developing the health sector. One of the CEE region's most populous countries.

Small but sophisticated medical device market. Imports supply most of the market. Other medical devices and diagnostic imaging have the largest market shares. High per capita spending in the Middle East Africa region. High single-digit market CAGR driven by the National Health Strategy.

The agricultural sector is responsible for one quarter of global greenhouse gas (GHG) emissions, and will play a central role as the world transitions to a low-carbon future. The livestock sector - and cattle ranching in particular - will be at the forefront of the policy debate, given its outsized contribution to emissions, but the transition will also impact the rest of the sector as governments move to regulate land and fertiliser use and incentivise the production of crop-based biofuels (see 'Environmental Regulation To Tackle Livestock & Fertilisers, Incentivise Biofuels', October 12 2017).

Second smallest market in the Asia Pacific (APAC) region. Per capita spending is one of the lowest in the world. Market growth will be below average for the region. Other medical devices and consumables have the largest market shares. The market is heavily reliant on imports. Domestic manufacturing is concentrated in Sialkot and centres mainly around steel surgical instruments and other hand held medical devices. Production is of a high quality but mostly destined for export.

Ambitious economic diversification plans coupled with a robust PPP framework will continue to attract foreign firms to the sultanate's infrastructure market. This will facilitate a sustained diversification of the competitive landscape. Our Key Projects Database indicates the dominance of domestic firms in Oman's construction sector has been eroded significantly since 2015 (when Omani firms accounted for 60% of the market). The market share of Omani firms has since fallen to 46%, a notable decline in such a short period (see 'Foreign Construction Players Increasing Market Share,' May 5 2015).